Optimizing essential, complex hematologic care for patients living with disabilities

C Caitlin Sarubbi (6Montefiore Medical Center/Albert Einstein College of Medicine, Department of Medicine, Bronx, United States) J Jennifer Miatech (1The University of Texas MD Anderson Cancer Center, Houston, United States) M Mark Forsberg (1MD Anderson, Stem Cell Transplantation & Cellular Therapy, Houston, United States) A Asha Demla (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) Z Zara Rahman (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) J Jessie Pawelek (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) D Debbie MItchell (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) S Stephanie Donald (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) C Cynthia Garcia (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) K Karen Suello (1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) K KaNoisha Codrington (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States) L Ligny Hunter (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States) R Ricky Garcia (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States) C Charles Martinez (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States) G Gabriela Rondon (6The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) G Gheath Alatrash (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) Y Yosra Aljawai (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) A Amin Alousi (20MD Anderson Cancer Center, Houston, United States) Q Qaiser Bashir (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) R Richard Champlin (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) G George Chen (Department of Chemistry Virginia Tech Blacksburg Virginia USA) C Chitra Hosing (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) J Jin Im (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) P Partow Kebriaei (MD Anderson Cancer Center) I Issa Khouri (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation & Cellular Therapy, Houston, United States) P Paul Lin D David Marin R Rohtesh Mehta (1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation & Cellular Therapy, Houston, United States) Y Yago Nieto (1The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States) A Amanda Olson (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) B Betul Oran (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) M Muzaffar Qazilbash (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) J Jeremy Ramdial (3The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States) U Uday Popat (1University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States) P Portia Smallbone (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) S Samer Srour (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States) P Priti Tewari (3Division of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX) C Christopher Flowers (1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX) E Elizabeth Shpall W Warren Fingrut (1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States)

Abstract

Abstract Background: People living with disabilities face unique challenges accessing care. Using stem cell transplantation (BMT) as an example, we investigated how to optimize essential, complex hematologic care delivery for patients (pts) living with disabilities. Methods: We conducted a mixed-method analysis to identify BMT pts living with disabilities & explore barriers they face to care. Our study team included those with lived experience as &/or expertise caring for people with disabilities. Starting in 7/2024, consecutive BMT pts at our Center were asked to report any physical/intellectual/sensory disabilities (clinicaltrials.gov NCT06431347), after an explanation re: the relevance of this information to their care. We retrospectively reviewed how identified disabilities were recorded/reported in the electronic health record (EHR) from initial BMT MD consult to discharge post-BMT. We also interviewed BMT pts with disabilities & their caregivers & providers & led a qualitative analysis to identify barriers/facilitators to care & develop best practices to optimize complex hematologic care delivery for pts with disabilities. Results: From 7/2024-7/2025, of 401 BMT pts who participated in the disability screening, 41 (10%; median age 64 yrs, range 23-76; 44% female; 37% non-White; 14 auto- & 27 allo-BMT) reported disabilities likely to impact care delivery: 20 physical, 5 intellectual, 15 sensory & 1 with a disability-related service animal. However, of these, only half (21/41, 51%) were discussed in the BMT pre-admission note or discharge summary (22/41, 54%) with less than half discussed in both (17/41, 41%). By disability category, intellectual disabilities were least commonly discussed in both notes (1/5, 20%), followed by sensory (5/15, 33%) & physical (10/20, 50%). Although most disabilities (33/41, 80%) were discussed in ≥1 BMT MD or allied healthcare note, 8/41 (20%) were not listed anywhere in the EHR: 1 physical (multiple digit loss), 2 intellectual (both learning disability), 5 sensory (4 hearing & 1 vision impairment). To explore care delivery in-depth, we interviewed 14 pts, 10 caregivers & 17 providers who shared lived experience as/caring for 41 BMT pts with disabilities (including peds & adult auto- & allo-BMT pts). 18 had physical disabilities: 7 used a wheelchair & 2 a walker/cane; 9 had missing limbs (8 lower & 1 upper extremity; 2 used prostheses), 1 spinal cord injury & 2 movement disorders. 14 had intellectual disabilities: 5 developmental disorders; 3 learning disabilities (1 ADHD, 2 dyslexia); 6 autism/neurodivergence. 7 had sensory disabilities: 3 visually & 4 hearing impaired. 2 had service animals. Qualitative analysis revealed 6 key domains impacting care for pts with disabilities: Disability stigma/bias; screening/documentation; autonomy/independence; barriers to care due to disability; accessibility/adaptability; & communication. Most participants described unique barriers to care due to disabilities. However, many pts were not asked & did not discuss their disabilities with the care team. Additionally, several did not share their disability due to fear of being treated differently or belief it was not relevant & consequently faced further hurdles to care. Pts described adaptive tools they employed, although independence/autonomy were frequently compromised by obstacles in accessing assistive devices/supports (eg placement/proximity of wheelchair/gait aids, hearing aids, prostheses; permission to use service animals). Pts with disabilities & their caregivers/providers shared examples of communication barriers & solutions. Based on these data, we generated detailed best practices to optimize complex hematologic care delivery to pts with disabilities, overall & for pts with specific physical, intellectual, or sensory disabilities. Recommendations included approaches to optimize pt disability data collection/recording/reporting, treatment eligibility assessment/decision making/preparations, pt-provider communication & provider-provider handover & pt safety & experience assessments/interventions.Conclusions: Our work will support stakeholders across hematology to advocate for policies/practices which uplift, empower & support pts with disabilities to receive essential complex hematologic care. Implementing these recommendations will help dismantle structural barriers to care, inform efforts to improve pt well-being & advance a more inclusive healthcare system for pts with disabilities.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 4392-4392
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (40)

C

Caitlin Sarubbi

6Montefiore Medical Center/Albert Einstein College of Medicine, Department of Medicine, Bronx, United States

J

Jennifer Miatech

1The University of Texas MD Anderson Cancer Center, Houston, United States

M

Mark Forsberg

1MD Anderson, Stem Cell Transplantation & Cellular Therapy, Houston, United States

A

Asha Demla

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

Z

Zara Rahman

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

J

Jessie Pawelek

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

D

Debbie MItchell

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

S

Stephanie Donald

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

C

Cynthia Garcia

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

K

Karen Suello

1The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

K

KaNoisha Codrington

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States

L

Ligny Hunter

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States

R

Ricky Garcia

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States

C

Charles Martinez

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation and Cellular Therapy, Houston, United States

G

Gabriela Rondon

6The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

G

Gheath Alatrash

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

Y

Yosra Aljawai

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

A

Amin Alousi

20MD Anderson Cancer Center, Houston, United States

Q

Qaiser Bashir

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

R

Richard Champlin

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

G

George Chen

Department of Chemistry Virginia Tech Blacksburg Virginia USA

C

Chitra Hosing

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

J

Jin Im

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

P

Partow Kebriaei

MD Anderson Cancer Center

I

Issa Khouri

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation & Cellular Therapy, Houston, United States

P

Paul Lin

D

David Marin

R

Rohtesh Mehta

1The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation & Cellular Therapy, Houston, United States

Y

Yago Nieto

1The University of Texas MD Anderson Cancer Center, Hematopathology, Houston, United States

A

Amanda Olson

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

B

Betul Oran

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

M

Muzaffar Qazilbash

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

J

Jeremy Ramdial

3The University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation & Cellular Therapy, Houston, United States

U

Uday Popat

1University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

P

Portia Smallbone

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

S

Samer Srour

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States

P

Priti Tewari

3Division of Pediatrics, Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

C

Christopher Flowers

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

E

Elizabeth Shpall

W

Warren Fingrut

1MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy, Houston, United States